29 related articles for article (PubMed ID: 19523878)
1. Brain traffic: subcellular transport of the amyloid precursor protein.
Mayeux R; St George-Hyslop P
Arch Neurol; 2009 Apr; 66(4):433-4. PubMed ID: 19364927
[No Abstract] [Full Text] [Related]
2. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
[TBL] [Abstract][Full Text] [Related]
3. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid TAU protein and amyloid beta42 in mild cognitive impairment: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination.
Ivanoiu A; Sindic CJ
Neurocase; 2005 Feb; 11(1):32-9. PubMed ID: 15804922
[TBL] [Abstract][Full Text] [Related]
5. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
[TBL] [Abstract][Full Text] [Related]
6. Will CSF analysis become routine in people with memory complaints?
Gauthier S
Lancet Neurol; 2009 Jul; 8(7):595-6. PubMed ID: 19523878
[No Abstract] [Full Text] [Related]
7. [Biomarkers in cerebrospinal fluid and blood in memory complaints].
Zetterberg H; Andreasen N; Blennow K
Lakartidningen; 2009 May 13-19; 106(20):1386-9. PubMed ID: 19585836
[No Abstract] [Full Text] [Related]
8. Do CSF biomarkers help clinicians predict the progression of mild cognitive impairment to dementia?
Mitchell AJ; Monge-Argilés JA; Sánchez-Paya J
Pract Neurol; 2010 Aug; 10(4):202-7. PubMed ID: 20647526
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?
Zetterberg H; Blennow K
J Alzheimers Dis; 2013; 33 Suppl 1():S361-9. PubMed ID: 22710917
[TBL] [Abstract][Full Text] [Related]
10. Advances on biological markers in early diagnosis of Alzheimer disease.
Padovani A; Borroni B; Di Luca M
Adv Clin Chem; 2005; 39():107-29. PubMed ID: 16013669
[No Abstract] [Full Text] [Related]
11. Biological markers in Alzheimer's disease.
Bailey P
Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S72-6. PubMed ID: 17469687
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
